XIAOLING LI: Open Payments
NPI 1598012908 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 2 | $76 |
| Smith+Nephew, Inc. | 1 | $59 |
| GENZYME CORPORATION | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: Xhance, NUCALA, TULA, DUPIXENT, LIBTAYO.
Industry payments across CA — which companies pay providers there.
